Iron in PDB 6o3i: Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

Enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

All present enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919):
1.13.11.52;

Protein crystallography data

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i was solved by S.F.Harris, A.Oh, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 74.17 / 2.69
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 85.062, 90.224, 130.237, 90.00, 90.00, 90.00
R / Rfree (%) 21.6 / 26.4

Other elements in 6o3i:

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) (pdb code 6o3i). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total 2 binding sites of Iron where determined in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i:
Jump to Iron binding site number: 1; 2;

Iron binding site 1 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 1 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe501

b:49.7
occ:1.00
FE A:HEM501 0.0 49.7 1.0
ND A:HEM501 2.0 49.8 1.0
NC A:HEM501 2.0 49.5 1.0
NB A:HEM501 2.0 49.3 1.0
NA A:HEM501 2.0 49.9 1.0
NE2 A:HIS346 2.1 48.9 1.0
N10 A:LKP502 2.1 47.4 1.0
C1D A:HEM501 2.9 50.1 1.0
C4D A:HEM501 3.0 50.0 1.0
C9 A:LKP502 3.0 47.5 1.0
C4B A:HEM501 3.0 49.6 1.0
C4C A:HEM501 3.0 49.8 1.0
C1B A:HEM501 3.0 49.7 1.0
CE1 A:HIS346 3.0 48.9 1.0
C1C A:HEM501 3.0 49.4 1.0
C4A A:HEM501 3.0 49.8 1.0
C1A A:HEM501 3.1 50.1 1.0
CD2 A:HIS346 3.1 49.5 1.0
C11 A:LKP502 3.3 48.4 1.0
CHD A:HEM501 3.3 50.5 1.0
CHA A:HEM501 3.4 50.5 1.0
CHC A:HEM501 3.4 50.2 1.0
CHB A:HEM501 3.4 50.2 1.0
ND1 A:HIS346 4.2 50.3 1.0
CG A:HIS346 4.2 49.3 1.0
C3D A:HEM501 4.2 50.7 1.0
C2D A:HEM501 4.2 50.4 1.0
C2C A:HEM501 4.2 50.0 1.0
C3C A:HEM501 4.2 50.1 1.0
N8 A:LKP502 4.2 46.1 1.0
C2A A:HEM501 4.3 50.6 1.0
C3A A:HEM501 4.3 50.4 1.0
C2B A:HEM501 4.3 49.8 1.0
C3B A:HEM501 4.3 50.0 1.0
C7 A:LKP502 4.4 47.5 1.0
CB A:ALA264 4.5 48.0 1.0

Iron binding site 2 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 2 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 2 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Fe501

b:56.4
occ:1.00
FE B:HEM501 0.0 56.4 1.0
NA B:HEM501 1.9 56.6 1.0
N10 B:LKP502 1.9 45.5 1.0
NC B:HEM501 2.0 56.3 1.0
ND B:HEM501 2.0 56.5 1.0
NB B:HEM501 2.0 56.2 1.0
NE2 B:HIS346 2.2 61.7 1.0
C9 B:LKP502 2.8 45.2 1.0
C4A B:HEM501 3.0 56.6 1.0
C1D B:HEM501 3.0 56.8 1.0
C4D B:HEM501 3.0 56.8 1.0
C4C B:HEM501 3.0 56.5 1.0
C1C B:HEM501 3.0 56.2 1.0
C1A B:HEM501 3.0 56.8 1.0
C1B B:HEM501 3.0 56.6 1.0
C4B B:HEM501 3.1 56.5 1.0
C11 B:LKP502 3.1 45.5 1.0
CE1 B:HIS346 3.1 61.5 1.0
CD2 B:HIS346 3.3 61.9 1.0
CHB B:HEM501 3.4 57.0 1.0
CHA B:HEM501 3.4 57.2 1.0
CHD B:HEM501 3.4 57.2 1.0
CHC B:HEM501 3.4 56.9 1.0
N8 B:LKP502 4.1 46.2 1.0
C7 B:LKP502 4.2 46.1 1.0
C3A B:HEM501 4.2 57.1 1.0
C2A B:HEM501 4.2 57.2 1.0
C2C B:HEM501 4.2 56.8 1.0
C3C B:HEM501 4.2 56.8 1.0
CB B:ALA264 4.3 53.3 1.0
C3D B:HEM501 4.3 57.2 1.0
ND1 B:HIS346 4.3 62.5 1.0
C2D B:HEM501 4.3 57.2 1.0
C2B B:HEM501 4.3 56.7 1.0
C3B B:HEM501 4.3 57.0 1.0
CG B:HIS346 4.4 60.9 1.0

Reference:

S.Kumar, J.P.Waldo, F.A.Jaipuri, A.Marcinowicz, C.Van Allen, J.Adams, T.Kesharwani, X.Zhang, R.Metz, A.J.Oh, S.F.Harris, M.R.Mautino. Discovery of Clinical Candidate (1R,4R)-4-((R)-2-((S)-6-Fluoro-5H-Imidazo[5, 1-A]Isoindol-5-Yl)-1-Hydroxyethyl)Cyclohexan-1-Ol (Navoximod), A Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. J.Med.Chem. V. 62 6705 2019.
ISSN: ISSN 0022-2623
PubMed: 31264862
DOI: 10.1021/ACS.JMEDCHEM.9B00662
Page generated: Sun Dec 13 16:46:54 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy